BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 25572913)

  • 1. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
    Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
    Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
    Chowdhry AK; Fung C; Chowdhry VK; Bergsma D; Dhakal S; Constine LS; Milano MT
    Leuk Lymphoma; 2018 May; 59(5):1180-1187. PubMed ID: 28862484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.
    Boukheris H; Ron E; Dores GM; Stovall M; Smith SA; Curtis RE
    Cancer; 2008 Dec; 113(11):3153-9. PubMed ID: 18823043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basaloid squamous cell carcinoma of the head and neck: location means everything.
    Fritsch VA; Lentsch EJ
    J Surg Oncol; 2014 May; 109(6):616-22. PubMed ID: 24464879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.
    Tiwana MS; Wu J; Hay J; Wong F; Cheung W; Olson RA
    Oral Oncol; 2014 Jul; 50(7):651-6. PubMed ID: 24731736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary lung cancers following a diagnosis of primary head and neck cancer.
    Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
    Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second course of radiation for new primary head-and-neck cancer: population-based study of survival.
    Milano MT; Zhang H
    Am J Clin Oncol; 2011 Aug; 34(4):367-71. PubMed ID: 20859195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes for head and neck squamous cell carcinoma arising after lymphoma.
    Moore MG; Bhattacharyya N
    Otolaryngol Head Neck Surg; 2008 Mar; 138(3):388-93. PubMed ID: 18312890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.
    Minn AY; Riedel E; Halpern J; Johnston LJ; Horning SJ; Hoppe RT; Goodman KA
    Br J Haematol; 2012 Nov; 159(3):329-39. PubMed ID: 22966754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK; Khanal A
    Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival.
    Kyrgidis A; Tzellos TG; Kechagias N; Patrikidou A; Xirou P; Kitikidou K; Bourlidou E; Vahtsevanos K; Antoniades K
    Eur J Cancer; 2010 Jun; 46(9):1563-72. PubMed ID: 20338745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes for second primary head and neck cancer: a matched analysis.
    Bhattacharyya N; Nayak VK
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):63-8. PubMed ID: 15632911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous head and neck cancers portend poor prognoses in lung cancer patients.
    Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
    Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.